This ADC product is comprised of an anti-CD22 monoclonal antibody (clone 10F4) conjugated via a AcBut linker to a Calicheamicin. The Calicheamicin is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated e
When you call, don't forget to mention that you found this ad on I do not wish to be contacted by telemarketers or representatives of any other website.